Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Artelo Biosciences Inc is a United States based development-stage biopharmaceutical company. It is focused on discovering, licensing, developing and commercializing treatments that control the endocannabinoid system. The company seeks to pursue technologies and programs that offer proprietary approaches to cannabinoid-based therapies, including those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds that promote the effectiveness of the endocannabinoid system. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease.
| Last: | $0.0011 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $0.0011 |
| Close: | $0.0011 |
| High: | $0.0011 |
| Low: | $0.0011 |
| Volume: | 875 |
| Last Trade Date Time: | 08/05/2025 11:04:31 am |
| Market Cap: | $2,927,182 |
|---|---|
| Float: | 1,786,590 |
| Insiders Ownership: | N/A |
| Institutions: | 7 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.artelobio.com |
| Country: | US |
| City: | Solana Beach |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Artelo Biosciences Inc Warrants(13/10/2025) (OTCMKTS: ATLEW).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
